
|Videos|May 20, 2015
What Lessons Have Been Learned from High Cost Hepatitis C Drugs?
Author(s)Davy James, Managing Editor
Marc O'Connor, Chief Operating Officer of Curant Health, discusses the main takeaways from the impact of hepatitis C drugs on specialty pharmacy.
Advertisement
Marc O'Connor, Chief Operating Officer of Curant Health, discusses the main takeaways from the impact of hepatitis C drugs on specialty pharmacy.
This video was recorded courtesy of Armada Health Care at the 2015 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
2
Current Pneumococcal Vaccination Recommendations: A Clinical Update
3
Semaglutide Reduces Time in Spent in Hospital, Admission Rates in Patients With Overweight or Obesity
4
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
5

























